Proliferative Capacity of Venous Ulcer Wound Fibroblasts in the Presence of Platelet-Derived Growth Factor

Abstract

Growth factors have been demonstrated to increase the proliferation of wound fibroblasts. Platelet-derived growth factor (PDGF) is a potent cell mitogen. However, the role of PDGF in chronic venous ulcers is inconclusive. This study investigated whether PDGF stimulates venous ulcer fibroblasts to proliferate. Fibroblasts (fb) were isolated from 8 venous ulcers wounds (w-fb) and normal skin (n-fb) of the ipsilateral thigh via punch biopsies. Fibroblasts were plated at 1,500 cells/dish in Dulbecco's Modified Eagle Medium + 10% calf serum (CM) and treated with/without PDGF-ab (10 ng/mL) for 15 days. Growth rates were calculated. Western blotting and immunocytochemistry staining determined basal levels for PDGF-a and-b receptors, respectively. Growth rates were significantly lower in w-fb than in n-fb (1,579 ±546 vs 13,782 ±5,882 cells/day, p = 0.019). PDGF-ab treatment caused n-fb to increase their proliferative capacity relative to complete media (20,393 ±6,572 vs 13,782 ±5,882 cells/day, p= 0.005). However, PDGF-ab had no significant effect on w-fb proliferation over CM (1,030 ±264 and 1,579 ±546 cells/day, p=0.15). In the presence of PDGF-ab, w-fb had a significantly attenuated growth rate over n-fb (1,030 ±264 vs 20,393 ±6,572 cells/day, p=0.019). Western blot and immunocytochemistry analysis revealed diminished basal levels of PDGF-a and-b receptors, respectively, in ulcer fibroblasts. Venous ulcer fibroblasts had decreased proliferation. PDGF-ab had no effect on the growth rate of venous ulcer fibroblasts. In venous ulcers, decreased basal levels of fibroblast PDGF-a and-b receptors may explain reduced proliferation. Further clinical studies are needed to elucidate the role growth factors may play in venous ulcers.

Get full access to this article

View all access options for this article.

References

Ross R , Glomset J , Kariya B , et al: A platelet-dependent serum factor that stimulates the proliferation of arterial smooth muscle cells in vitro. Proc Natl Acad Sci USA 71:1207-1210, 1974.

Moffatt CJ , O'Hare L : Venous leg ulceration: Treatment by high compression bandaging. Ostomy Wound Manage 41:16-20, 1995.

Wilkinson LS , Bunker C , Edwards JCW , et al: Leukocytes: Their role in the etiopathogenesis of skin damage in venous disease. J Vasc Surg 17:669-675, 1993.

Ross R , Raines EW , Bowen-Pope DF : The biology of platelet-derived growth factor. Cell 46:155-169, 1986.

Mustoe TA , Pierce GF , Morishima C , et al: Growth factor-induced acceleration of tissue repair through direct and inductive activities in a rabbit dermal ulcer model. J Clin Invest 87:694-703, 1991.

Krane JF , Murphy DP , Gottlieb AB , et al: Increased dermal expression of platelet-derived growth factor receptors in growth-activated skin wounds and psoriasis. J Invest Dermatol 96:983-986, 1991.

Deuel TF , Kawahara RS , Mustoe TA , et al: Growth factors and wound healing: Platelet-derived growth factor as a model cytokine. Ann Rev Med 42:567-584, 1991.

Hasan A , Murata H , Falabella A , et al: Dermal fibroblasts from venous ulcers are unresponsive to the action of transforming growth factor-B1. J Dermatol Sci 16:59-66, 1997.

Hayflick L , Moorhead PS : The human fibroblast and a new model for cellular senescence. Exp Cell Res 25:585-588, 1961.

10.

Stanley AC , Park HY , Phillips TJ , et al: Reduced growth of dermal fibroblasts from chronic venous ulcers can be stimulated with growth factors. J Vasc Surg 26:994-1001, 1997.

11.

Bergan JJ , Eklof B , Kistner RL , et al: Classification and grading of chronic venous disease in the lower limbs: A consensus statement. In: Handbook of Venous Disorders: Guidelines of the American Venous Forum, ed. 1, ed. by Gloviczki P , Yao JST . New York: Chapman and Hall, 1996, pp 652-660.

12.

Gilchrest BA , Karassik RL , Wilkins LM , et al: Autocrine and paracrine growth stimulation of cells derived from human skin. J Cell Physiol 117:235-240, 1983.

13.

Park HY , Campisi J : Posttrranslational control of cyclic AMP-dependent protein kinase by phorbol ester in normal but not in chemically transformed 3T3 cells. Cancer Res 50:7145-7152, 1990.

14.

Laemmli UK : Cleavage of structural proteins during the assembly of the head of bacteriophage. Nature 227:680-685, 1970.

15.

Wieman TJ , and the Becaplermin Gel Studies Group : Clinical efficacy of becaplermin (rhPDGF-BB) gel. Am J Surg 176(suppl):74S-79S, 1998.

16.

Eriksson A , Siegbahn A , Westermark B , et al: PDGFa and-b receptors activate unique and common signal transduction pathways. EMBO J 11:543-550, 1992.

17.

Heldin CH , Ostman A , Ronnstrand L : Signal transduction via platelet-derived growth factor receptors. Biochimica Biophysica Acta F79-F113, 1998.